Moreover, neurodegenerative disorders including Alzheimer’s disease (AD), Wernicke’s encephalopathy, epilepsy, Huntington’s disease, and cerebral ischemia have demonstrated increased TSPO in the cerebellum, olfactory lobes during disease development and progression stages, and have stimulated researchers to improve targeted neuroinflammation therapies [12–14]. Here, TSPO is linked to Alzheimer disease.